Analysis of the efficacy of direct hemoperfusion with polymyxin B-immobilized fiber (PMX-DHP) according to the prognostic factors in patients with colorectal perforation

Surgery Today

Volumn 43, Issue 9, 2013, Pages 1031-1038

  Sugimoto, Kiichi ^a   Sato, Koichi ^a   Maekawa, Hiroshi ^a   Sakurada, Mutsumi ^a   Orita, Hajime ^a   Ito, Tomoaki ^a   Sakamoto, Kazuhiro ^b  

^a JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

APACHE II score; Colorectal perforation; Direct hemoperfusion with polymyxin B immobilized fiber (PMX DHP); Prognostic factor; Sepsis

Indexed keywords

POLYMYXIN B;

ADULT; AGED; APACHE; ARTICLE; COLON DIVERTICULOSIS; COLON PERFORATION; COLORECTAL CANCER; COLORECTAL SURGERY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HEMOPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RECTUM PERFORATION; RETROSPECTIVE STUDY; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVOR; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CECUM; COLON; DIGESTIVE SYSTEM SURGICAL PROCEDURES; FEMALE; HEMOPERFUSION; HUMANS; INTESTINAL PERFORATION; MALE; MIDDLE AGED; POLYMYXIN B; PROGNOSIS; RECTUM; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 84882258291     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-012-0399-y     Document Type: Article

References (27)

1. Krivanek S, Armbruster C, Dittrich K, Beckerhinn P. Perforated colorectal cancer. Dis Colon Rectum. 1996;39:1409-14.
2. Nespoli A, Ravizzini C, Trivella M, Segala M. The choice of surgical procedure for peritonitis due to colonic perforation. Arch Surg. 1993;128:814-8.
3. Shinkawa H, Yasuhara H, Naka S, Yanagie H, Nojiri T, Furuya Y, et al. Factors affecting the early mortality of the patients with nontraumatic colorectal perforation. Surg Today. 2003;33:13-7.
4. Vincent JL, Laterre PF, Cohen J, Burchardi H, Bruining H, Lerma FA, et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock. 2005;23:400-5.
5. Ono S, Tsujimoto H, Matsumoto A, Ikuta S, Kinoshita M, Mochizuki H. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber. Am J Surg. 2004;188:150-6.
6. Cruz DN, Perazella M, Bellomo R, de Cal M, Polanco N, Corradi V, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care. 2007. doi: 10.1186/cc5780.
7. Kojika M, Sato N, Yaegashi Y, Suzuki Y, Suzuki K, Nakae H, et al. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Ther Apher Dial. 2006;10:12-8.
8. Sato K, Maekawa H, Sakurada M, Orita H, Komatsu Y. Direct hemoperfusion with polymyxin B immobilized fiber for abdominal sepsis in Europe. Surg Today. 2011;41:754-60.
9. Akaike H. Information theory and an extension of the maximum likelihood principle. In: Petrov BN, editor. Second International Symposium on Information Theory. Budapest: Akademiai Kiado; 1973. p. 267-81.
10. Nagorney DN, Adson MA, Pemberton JH. Sigmoid diverticulitis with perforation and generalized peritonitis. Dis Colon Rectum. 1985;28:71-5.
11. American College of Chest Physicians and Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-75.
12. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995;273:117-23.
13. Smail N, Messiah A, Edouard A, Descorps-Declere A, Duranteau J, Vigue B, et al. Role of systemic inflammatory response syndrome and infection in the occurrence of early multiple organ dysfunction syndrome following severe trauma. Intensive Care Med. 1995;21:813-6.
14. Pittet D, Rangel-Frausto MS, Li N, Costigan M, Rempe L, Jebson P, et al. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med. 1995;21:302-9.
15. Nishida K, Okinaga K, Miyazawa Y, Suzuki K, Tanaka M, Hatano M, et al. Emergency abdominal surgery in patients aged 80 years and older. Surg Today. 2000;30:22-7.
16. Sun D, Aikawa N. The natural history of the systemic inflammatory response syndrome and the evaluation of SIRS criteria as a predictor of severity in patients hospitalized through emergency services. Keio J Med. 1999;48:28-37.
17. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-29.
18. Komatsu S, Shimomatsuya T, Nakajima M, Ono S, Maruhashi K. Severity scoring systems for prognosis and efficacy of polymyxin B-immobilized fiber treatment for colonic perforation. Surg Today. 2006;36:807-10.
19. Horiuchi A, Watanabe Y, Doi T, Sato K, Yukumi S, Yoshida M, et al. Evaluation of prognostic factors and scoring system in colonic perforation. World J Gastroenterol. 2007;13:3228-31.
20. Ochiai T, Hiranuma S, Takiguchi N, Ito K, Kawaguchi A, Iwai T, et al. SOFA score predicts postoperative outcome of patients with colorectal perforation. Hepatogastroenterology. 2004;51:1007-10.
21. Komatsu S, Shimomatsuya T, Nakajima M, Amaya H, Kobuchi T, Shiraishi S, et al. Prognostic factors and scoring system for survival in colonic perforation. Hepatogastroenterology. 2005;52:761-4.
22. Aoki H, Kodama M, Tani T, Hanasawa K. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg. 1994;167:412-7.
23. Nemoto H, Nakamoto H, Okada H, Sugahara S, Moriwaki K, Arai M, et al. Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif. 2001;19:361-8.
24. Shimizu T, Hanasawa K, Tani T, Endo Y, Kurumi Y, Ikeda T, et al. Changes in circulating levels of calcitonin gene-related peptide and nitric oxide metabolites in septic patients during direct hemoperfusion with polymyxin B-immobilized fiber. Blood Purif. 2003;21:237-43.
25. Shimizu T, Hanazawa K, Sato K, Umeki M, Koga N, Naganuma T, et al. Direct hemoperfusion with polymyxin-B-immobilized fiber columns improves septic hypotension and reduces inflammatory mediators in septic patients with colorectal perforation. Langenbecks Arch Surg. 2009;394:303-11.
26. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock. The EUPHAS randomized controlled trial. JAMA. 2009;301:2445-52.
27. Vincent JL. Polymyxin B hemoperfusion and mortality in abdominal septic shock. JAMA. 2009;302:1968.